April 12 (Reuters) – Valeant Pharmaceuticals International
Inc said on Tuesday that it received a notice of
default from its bond holders as a result of a delay filing its
annual report.
The post UPDATE 1-Drugmaker Valeant’s bond holders intend to call default appeared first on NASDAQ.